International Patients

New Alzheimer’s Medication Now Available in the UK for European Patients

Early-stage Alzheimer’s disease treatment is available now in the UK

If your loved one has been diagnosed with early Alzheimer’s disease or mild cognitive impairment (MCI), you may now be eligible to receive new Alzheimer’s medications in the UK. These Alzheimer’s disease treatments have been recently licensed and are not yet accessible in most parts of Europe.

As global leaders in Alzheimer’s research and clinical trials, Re:Cognition Health is one of the first clinics to offer these medications, designed to target amyloid plaques in the brain and potentially slow disease progression.

Call now: 0800 802 1030

Why patients are travelling to the UK for treatment

These newly licensed Alzheimer’s medications are not yet available across much of Europe, and timelines for wider availability remain uncertain.

Patients from across Europe and beyond choose to travel to our specialist UK clinics to begin this pioneering treatment without delay. Re:Cognition Health provides fast, expert-led care with no referral required.

Who is eligible?

To access these new Alzheimer’s treatments, patients must meet the following criteria:

  • Eligibility: Confirmation of elevated amyloid protein by Amyloid PET or CSF analysis is mandatory.
  • Treatment: Bi-weekly intravenous infusion or monthly intravenous infusion with monitoring via MRI scans.
  • Required: A study program partner (family member or friend) for regular contact.
  • Follow-Up: Recommended amyloid re-assessment at 12 months, then at 18 or 24 months.

 

Why choose the UK for treatment?

  • Access to new Alzheimer’s medication ahead of most European countries
  • Leading specialists and a dedicated memory clinic with extensive experience
  • No referral needed – you can self-refer directly to us
  • Convenient London location, accessible from across Europe
  • Quick appointments with no NHS waiting lists

Please note: Patients are responsible for arranging their own travel and accommodation.

 

Hear from a patient: Mike’s Story

Wondering what it’s like to travel to the UK for Alzheimer’s treatment? Mike, one of our patients, shares his personal journey and how early diagnosis and access to new medication made a difference.

Read Mike’s story: https://recognitionhealth.com/mikes-story/

 

How soon can I be seen?

We understand the importance of early detection, so we do not have lengthy waiting lists. We get prospective patients screened as soon as possible for an assessment and schedule a follow-up appointment afterwards.

 

What happens next?

  • Contact Re:Cognition Health to express interest
  • Provide relevant medical history and diagnostic scans
  • Attend an assessment at our London clinic
  • If eligible, begin Alzheimer’s treatment promptly

The Harley Street Medical District

The world-renowned Harley Street Medical District is a historic centre of medical excellence in the heart of London. With over 5,000 expert specialists and clinics, it has been at the forefront of global healthcare for more than a century. Patients from around the world choose Harley Street for its outstanding, personalised care delivered with discretion and expertise. Our clinic is proudly located in the very centre of this prestigious district. Surrounded by luxury hotels, fine dining, and boutique shopping, international patients enjoy both comfort and convenience. Here, world-class treatment is matched by a warm welcome and an exceptional experience.

Take the first step towards treatment

Register Now

If you’re based in Europe and looking for access to new Alzheimer’s medication, Re:Cognition Health is here to help.

Start the process now and access Alzheimer’s medications that are currently only available in the UK.